Business Context and Reporting Period
Company: Humana Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 1999
Business Overview: Humana is a health services company facilitating care delivery through HMOs and PPOs to approximately 6.1 million medical members. Operations are reported in three segments: Commercial, Public Sector (Medicare/Medicaid), and TRICARE.
Key Financial Metrics
| Metric | Q1 1999 | Q1 1998 |
|---|---|---|
| Total Revenues | $2,477 million | $2,402 million |
| Premium Revenues | $2,428 million | $2,352 million |
| Net (Loss) Income | $(16) million | $50 million |
| (Loss) Earnings Per Share | $(0.10) | $0.30 |
| Operating Cash Flow | $(192) million | $(310) million |
| Cash and Equivalents (End of Period) | $636 million | $556 million |
| Total Debt (Short-term + Long-term) | $779 million | N/A (Data not explicitly aggregated in text) |
| Medical Expense Ratio | 84.3% (88.0% incl. special items) | 83.1% |
Material Changes vs. Prior Period
- Profitability Reversal: The company reported a net loss of $16 million compared to net income of $50 million in the prior year. This was primarily driven by a $90 million charge for additional medical claims expense.
- Revenue Growth: Total revenues increased 3.1% to $2,477 million, driven by a 3.2% increase in premium revenues despite membership declines in Commercial and Medicare lines.
- Membership Trends: Fully-insured commercial membership declined by 89,800, and Medicare HMO membership declined by 21,300 due to market closures in Florida and pricing discipline.
- Cash Flow Improvement: Net cash used in operating activities improved to $(192) million from $(310) million in the prior year, though still negative.
Guidance, Outlook, and Risks
Unusual Items and Management Commentary
- Additional Medical Claims Expense: A $90 million charge was recorded, comprising:
- $50 million for premium deficiencies (probable future losses).
- $35 million to strengthen medical claims payable due to higher-than-expected cost trends in PPO and Medicare products.
- $5 million payment to Columbia/HCA to resolve contractual issues.
- Offsetting Gains: A $12 million gain on the sale of a tangible asset and a $5 million favorable development in run-off workers' compensation liabilities partially offset the charges.
- Excluding Special Items: Management notes that excluding the $90 million charge and tangible asset gain, adjusted net income would have been $33 million ($0.20 per share).
Outlook and Guidance
- Membership: Commercial membership is expected to increase 3-5% for the remainder of 1999; Medicare membership is expected to be flat to slightly down.
- Cost Trends: Medical cost trends (8.3% in Commercial) exceeded premium yield increases. Management warns there is no assurance trends will not continue to increase.
- Debt Repayment: The company intends to pay an additional $200 million of outstanding debt using subsidiary dividends in 1999.
Risks and Contingencies
- Government Contracts: Risks associated with the renewal of Medicare, Medicaid, and TRICARE contracts. Legislative proposals could alter reimbursement rates.
- Puerto Rico: The company intends to close its Puerto Rico Medicaid market upon contract expiration (April 30, 1999) unless a favorable renewal is reached; negotiations are ongoing.
- Year 2000 (Y2K): Estimated total project cost is $26 million. 95% of core systems are remediated as of March 31, 1999, with completion expected by Q3 1999. Risks remain regarding third-party vendor readiness.
- Legal Proceedings: A consolidated securities class action regarding the PCA acquisition is set for trial in January 2001. Management believes allegations are without merit.
Investor Verification Checklist
- Verify the sustainability of medical cost trends, specifically the 8.3% increase in commercial costs and the impact of provider risk-sharing failures.
- Confirm the status of contract negotiations for the Puerto Rico Medicaid market and the potential financial impact of exiting the market.
- Monitor the progress of the Year 2000 remediation project, particularly the readiness of third-party vendors and government agencies.
- Assess the company's ability to refinance its $779 million in commercial paper borrowings and maintain compliance with debt covenants.
- Review the outcome of the pending securities litigation regarding the PCA acquisition.